↓ Skip to main content

A “reverse pharmacology” approach for developing an anti-malarial phytomedicine

Overview of attention for article published in Malaria Journal, March 2011
Altmetric Badge

Mentioned by

wikipedia
4 Wikipedia pages

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
149 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A “reverse pharmacology” approach for developing an anti-malarial phytomedicine
Published in
Malaria Journal, March 2011
DOI 10.1186/1475-2875-10-s1-s8
Pubmed ID
Authors

Merlin L Willcox, Bertrand Graz, Jacques Falquet, Chiaka Diakite, Sergio Giani, Drissa Diallo

Abstract

A "reverse pharmacology" approach to developing an anti-malarial phytomedicine was designed and implemented in Mali, resulting in a new standardized herbal anti-malarial after six years of research. The first step was to select a remedy for development, through a retrospective treatment-outcome study. The second step was a dose-escalating clinical trial that showed a dose-response phenomenon and helped select the safest and most efficacious dose. The third step was a randomized controlled trial to compare the phytomedicine to the standard first-line treatment. The last step was to identify active compounds which can be used as markers for standardization and quality control. This example of "reverse pharmacology" shows that a standardized phytomedicine can be developed faster and more cheaply than conventional drugs. Even if both approaches are not fully comparable, their efficiency in terms of public health and their complementarity should be thoroughly considered.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 <1%
Uganda 1 <1%
Indonesia 1 <1%
United Kingdom 1 <1%
United States 1 <1%
Unknown 144 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 29 19%
Researcher 19 13%
Student > Master 17 11%
Student > Postgraduate 10 7%
Other 9 6%
Other 35 23%
Unknown 30 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 29 19%
Medicine and Dentistry 21 14%
Chemistry 18 12%
Pharmacology, Toxicology and Pharmaceutical Science 16 11%
Social Sciences 7 5%
Other 19 13%
Unknown 39 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 September 2020.
All research outputs
#7,454,951
of 22,790,780 outputs
Outputs from Malaria Journal
#2,448
of 5,561 outputs
Outputs of similar age
#39,155
of 108,141 outputs
Outputs of similar age from Malaria Journal
#18
of 42 outputs
Altmetric has tracked 22,790,780 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,561 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,141 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.